Deniz Akdis

Deniz Akdis

Auto-generated profile, based on publicly available information

Deniz Akdis

University Heart Center, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich CH-8091

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2024 in Allergy
Verified
Journal Article
Open access
Na SunNa Sun
Na Sun
IOIsmail Ogulur
Ismail Ogulur
YMYasutaka Mitamura
Yasutaka Mitamura
DYDuygu Yazici
Duygu Yazici
YPYagiz Pat
Yagiz Pat
CACezmi A. Akdis
Cezmi A. Akdis
The prevalence of many chronic noncommunicable diseases has been steadily rising over the past six decades. During this time, over 350,000 new chemical substances have been introduced to the lives of humans. In recent years, the epithelial barrier theory came to light explaining the growing prevalence and exacerbations of these diseases worldwide. It attributes their onset to a functionally impaired epithelial barrier triggered by the toxicity of the exposed substances, associated with microbial dysbiosis, immune system activation, and inflammation. Diseases encompassed by the epithelial barrier theory share common features such as an increased prevalence after the 1960s or 2000s that cannot (solely) be accounted for by the emergence of improved diagnostic methods. Other common traits include epithelial barrier defects, microbial dysbiosis with loss of commensals and colonization of opportunistic pathogens, and circulating inflammatory cells and cytokines. In addition, practically unrelated diseases that fulfill these criteria have started to emerge as multimorbidities during the last decades. Here, we provide a comprehensive overview of diseases encompassed by the epithelial barrier theory and discuss evidence and similarities for their epidemiology, genetic susceptibility, epithelial barrier dysfunction, microbial dysbiosis, and tissue inflammation.

8 March 2023 in Heart
Verified
Journal Article
Closed access
PDF file
NMNadine Molitor
Nadine Molitor
DHDaniel Hofer
Daniel Hofer
TÇTolga Çimen
Tolga Çimen
AGAlessio Gasperetti
Alessio Gasperetti
DADeniz Akdis
Deniz Akdis
ASArdan M. Saguner
Ardan M. Saguner
Introduction Implantable cardioverter-defibrillators (ICDs) can prevent sudden cardiac death due to ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). The aim of our study was to assess the cumulative burden, evolution and potential triggers of appropriate ICD shocks during long-term follow-up, which may help to reduce and further refine individual arrhythmic risk in this challenging disease. Methods This retrospective cohort study included 53 patients with definite ARVC according to the 2010 Task Force Criteria from the multicentre Swiss ARVC Registry with an implanted ICD for primary or secondary prevention. Follow-up was conducted by assessing all available patient records from patient visits, hospitalisations, blood samples, genetic analysis, as well as device interrogation and tracings. Results Fifty-three patients (male 71.7%, mean age 43±2.2 years, genotype positive 58.5%) were analysed during a median follow-up of 7.9 (IQR 10) years. In 29 (54.7%) patients, 177 appropriate ICD shocks associated with 71 shock episodes occurred. Median time to first appropriate ICD shock was 2.8 (IQR 3.6) years. Long-term risk of shocks remained high throughout long-term follow-up. Shock episodes occurred mainly during daytime (91.5%, n=65) and without seasonal preference. We identified potentially reversible triggers in 56 of 71 (78.9%) appropriate shock episodes, the main triggers representing physical activity, inflammation and hypokalaemia. Conclusion The long-term risk of appropriate ICD shocks in patients with ARVC remains high during long-term follow-up. Ventricular arrhythmias occur more often during daytime, without seasonal preference. Reversible triggers are frequent with the most common triggers for appropriate ICD shocks being physical activity, inflammation and hypokalaemia in this patient population.

29 August 2025 in EP Europace
Verified
Journal Article
Open access
JRJie Ren
Jie Ren
ZHZhenliang Hu
Zhenliang Hu
LWLingmin Wu
Lingmin Wu
DADeniz Akdis
Deniz Akdis
WYWeiquan Ye
Weiquan Ye
LCLiang Chen
Liang Chen
Aims: Arrhythmogenic cardiomyopathy (ACM) is a genetically-determined disease characterized by malignant arrhythmias and sudden cardiac death, particularly in young individuals. Mutations in desmosomal genes are a major cause of ACM, but the role of desmocollin-2 (DSC2) remains understudied. Methods and results: We conducted a multi-cohort study with 52 ACM patients, 29 with dilated cardiomyopathy (DCM), 17 with hypertrophic cardiomyopathy (HCM), and 45 controls. Immunofluorescence, immunohistochemical staining, and western blot were used to assess DSC2 expression. DSC2 expression was significantly reduced in ACM myocardium compared to controls and other cardiomyopathies (P < 0.0001), consistent across ACM subtypes and validated in an independent cohort. DSC2 down-regulation correlated with clinical characteristics such as age at onset of arrhythmia and heart transplantation. DSC2 reduction in the right ventricle effectively discriminated ACM patients from controls (ROC AUC = 0.8017, P < 0.0001) and distinguished ACM from other cardiac diseases. Immunohistochemical staining in the Swiss cohort confirmed that 11 out of 12 (91.7%) ACM cases exhibited significantly reduced DSC2 signal intensity compared to normal donors. RNA-Seq analysis revealed significant down-regulation of DSC2 genes in ACM tissues. Conclusion: DSC2 remodelling is a hallmark of ACM, harbouring significant diagnostic implications. DSC2 reduction is a robust biomarker for ACM, showing high sensitivity and specificity across different subtypes. Future research should elucidate the mechanisms underlying DSC2 down-regulation.

1 July 2026 in Open Heart
Verified
Journal Article
Open access
PDF file
LTLucas Tramèr
Lucas Tramèr
DADeniz Akdis-Weidmann
Deniz Akdis-Weidmann
TDThierry G Donati
Thierry G Donati
AAAndrea Agbariah
Andrea Agbariah
FGFu Guan
Fu Guan
FDFirat Duru
Firat Duru
Background Arrhythmogenic cardiomyopathy (ACM) is a leading cause of sudden cardiac death in young adults and athletes. It is mostly genetically determined, with causal variants predominantly affecting desmosomal genes. Approximately one-third of patients remain gene-elusive despite extensive testing. Gene-elusive patients often report significantly higher lifetime exercise exposure than those with desmosomal ACM, suggesting a disproportionate role of exercise in this subgroup, also termed ‘exercise-induced ACM’. Yet, the effect of exercise history on the clinical characteristics and prognosis of this phenotype remains scarce.Methods In this retrospective, single-centre cohort study, we included patients with definite or borderline ACM and negative genetic testing for ACM-associated genes. Exercise exposure was quantified with a standardised sports activity survey or from medical records. Competitive athletes were defined by an exercise exposure ≥24 metabolic equivalent of task-hour/week for ≥6 consecutive years and regular participation in competitive events. Life-threatening ventricular arrhythmias (LTVA) were defined as sustained ventricular tachycardia, ventricular fibrillation or appropriate implantable cardioverter-defibrillator therapies.Results 46 patients (26 athletes, 20 non-athletes) were followed for a median of 7.5 years. At diagnosis, most athletes (77%) had definite right-ventricular ACM, compared with only 40% of non-athletes (p=0.025). Compared with non-athletes, athletes had a larger end-diastolic right-ventricular volume, while other imaging findings did not differ significantly. Athletes showed a distinct electrical phenotype with a shorter QTc (424 ms vs 449 ms, p<0.001), more T-wave inversions (4.0 vs 2.40, p=0.047) and a higher hazard of LTVA, death or heart transplantation during follow-up (HR 2.67, 95% CI 1.11 to 6.44, p=0.029).Conclusion In gene-elusive ACM, a history of competitive athletic participation was associated with more extensive repolarisation abnormalities, larger right ventricular volumes and a higher hazard of adverse outcomes during follow-up. These associations require validation in prospective multicentre cohorts, particularly regarding the relationship between exercise exposure and arrhythmic risk.